Glass Lewis & Company, the proxy advisory firm, is recommending that Allergan shareholders support Pershing Square Capital Management’s push for a special meeting of shareholders as part of its joint bid with Valeant Pharmaceuticals to acquire the Botox maker.

from DealBook» Mergers & Acquisitions http://ift.tt/1uiRslD
via IFTTT

Advertisements